Fundraising FoxLuminopia
Aspen, US · Founded 2015 · Delaware corporation · 10 known investors
Find your way into Luminopia
Each arrow is one introduction. Sign up to fill in the first one.
Ask Michael Abbate to introduce you to Dean Travers
You →Michael · together at Odin →Dean
Ask Jamie Chen to introduce you to Scott Xiao
You →Jamie · together at Odin →Scott
Ask Sam Okafor to introduce you to Hank Wu
You →Sam · together at Luminopia →Hank
- Drew Mowery60 people can intro you
Sign up to find every way you can get introduced to Luminopia
- Your email: who you already know at Luminopia, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Luminopia team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Luminopia is an FDA-cleared binocular therapy for amblyopia in children aged 4-12 that uses a VR headset to stream the child's favorite TV shows as treatment, replacing traditional eye patches. Clinically tested in US trials, the therapy is prescribed by doctors and requires one hour of use per day, six days a week.
Founders & leadership
Luminopia was founded in 2015 by Scott Xiao and Dean Travers.
Investors · 10
How we know: ShangBay Capital LLC's portfolio page · the company's own site · a partner's Signal profile · funding news · visionmonday.com · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
How we know: collabfund.com · Not right? Tell us
How we know: the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: NXT Ventures's portfolio page · Not right? Tell us
How we know: Sony Ventures Corporation's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
Also in the syndicate · 2
Reported raises · per SEC filings
Form D private placements$36.5M disclosed across 7 rounds · 2016–2023
▶$15.8MraisedJun 2023 · 10 investors · BiotechnologyRule 506(b)
- Scott XiaoExecutive Officer, Director
- Casey TanseyDirector
- Robert LangerDirector
- Dean TraversDirector
- William DaiDirector
- Mark JacobsteinDirector
- Offering amount
- $16.8M
- Amount sold
- $15.8M
- First sale
- Jun 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4.1MraisedOct 2022 · 15 investors · BiotechnologyRule 506(b)
- Jeffrey DunnDirector
- Scott XiaoExecutive Officer, Director
- Dean TraversDirector
- Robert LangerDirector
- Mark JacobsteinDirector
- Michelle LeeDirector
- William DaiDirector
- Offering amount
- $5.1M
- Amount sold
- $4.1M
- First sale
- Oct 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$11.1MraisedDec 2019 · 29 investors · Other Health CareRule 506(b)
- Scott XiaoExecutive Officer
- Mark JacobsteinDirector
- Jeffrey DunnDirector
- Dean TraversExecutive Officer, Director, Promoter
- Joi ItoDirector
- Robert LangerDirector
- Offering amount
- $13.6M
- Amount sold
- $11.1M
- First sale
- Nov 2019
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$3.6MraisedSep 2017 · 8 investors · Other Health CareRule 506(b)
- SCOTT XIAOExecutive Officer, Director
- ALEXANDER WENDLANDExecutive Officer, Director
- MARK DOCKSERExecutive Officer
- DEAN A. TRAVERSExecutive Officer, Director, Promoter
- Offering amount
- $5.1M
- Amount sold
- $3.6M
- Minimum investment
- $10K
- First sale
- Jun 2017
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$1.3MraisedSep 2017 · 3 investors · Other Health CareRule 506(b)
- SCOTT XIAOExecutive Officer, Director
- MARK DOCKSERExecutive Officer
- DEAN A. TRAVERSExecutive Officer, Director, Promoter
- ALEXANDER WENDLANDExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $1.3M
- Minimum investment
- $25K
- First sale
- Sep 2017
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$410KraisedDec 2016 · 8 investors · OtherRule 506(b)
- SCOTT XIAOExecutive Officer, Director
- ALEXANDER WENDLANDExecutive Officer, Director
- DEAN A. TRAVERSExecutive Officer, Director
- Offering amount
- $700K
- Amount sold
- $410K
- First sale
- Oct 2016
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$250KraisedJul 2016 · 7 investors · OtherRule 506(b)
- DEAN A. TRAVERSExecutive Officer, Director
- SCOTT XIAOExecutive Officer, Director
- ALEXANDER WENDLANDExecutive Officer, Director
- Offering amount
- $500K
- Amount sold
- $250K
- First sale
- Jul 2016
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Luminopia went on to found or lead other companies.
Related companies · 3
Companies working in the same space as Luminopia.
In the news
Frequently asked questions
- What does Luminopia do?
- Luminopia is an FDA-cleared binocular therapy for amblyopia in children aged 4-12 that uses a VR headset to stream the child's favorite TV shows as treatment, replacing traditional eye patches. Clinically tested in US trials, the therapy is prescribed by doctors and requires one hour of use per day, six days a week.
- Who founded Luminopia?
- Luminopia was founded by Scott Xiao, Dean Travers in 2015.
- Who are Luminopia's investors?
- Luminopia's investors include ShangBay Capital LLC, Bantam Group, Collaborative Fund, Good Friends, NXT Ventures, Sony Ventures Corporation, US Venture Partners, U.S. Venture Partners.
- How much funding has Luminopia raised?
- Luminopia has disclosed $36.5M raised across 7 rounds.
- Where is Luminopia headquartered?
- Luminopia is headquartered in Aspen, US.